Dayvigo is a prescription medication used to treat insomnia [1]. It is classified as a hypnotic medication, specifically a dual-acting orexin receptor antagonist [2].
How does Dayvigo work?
Dayvigo works by blocking the action of orexin, a neuropeptide that promotes wakefulness. By inhibiting orexin signaling in the brain, Dayvigo helps to reduce the drive to stay awake and facilitates sleep onset and maintenance [2][3].
What are the different strengths of Dayvigo?
Dayvigo is available in two strengths: 5 mg and 10 mg [1]. The dosage prescribed depends on individual patient needs and medical guidance.
When does Dayvigo's patent expire?
The patent expiration date for Dayvigo is a key consideration for the development of potential generic alternatives. DrugPatentWatch.com tracks these patent timelines. Information on specific patent expiry dates for Dayvigo can be found on their website [4].
What are the common side effects of Dayvigo?
Common side effects associated with Dayvigo include sleepiness, headache, and unusual dreams [1]. Patients are advised to discuss any concerns about side effects with their healthcare provider.
Who manufactures Dayvigo?
Dayvigo is manufactured by Eisai Inc. [1].
How does Dayvigo compare to other insomnia medications?
Dayvigo belongs to a class of drugs called orexin receptor antagonists, which is a different mechanism of action compared to older hypnotics like benzodiazepines or Z-drugs. This dual-acting orexin receptor antagonism aims to reduce sleep-promoting signals while also suppressing wakefulness-promoting signals [2].
What are the risks associated with Dayvigo?
Potential risks associated with Dayvigo include next-day impairment of driving or other activities requiring mental alertness. It also carries a risk of complex sleep behaviors, such as sleepwalking or sleep-driving, although these are rare [1].
Can Dayvigo be used for other sleep disorders?
Dayvigo is specifically indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance [1]. Its use for other sleep disorders has not been established.
What is the typical patient profile for Dayvigo?
Dayvigo is prescribed for adults diagnosed with insomnia. The decision to prescribe Dayvigo is made by a healthcare professional based on a patient's medical history and the nature of their insomnia [1].
What are the regulatory approvals for Dayvigo?
Dayvigo has received approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) for its indicated use in treating insomnia [1].
How does orexin signaling influence sleep?
Orexin is a neurotransmitter system in the brain that plays a crucial role in regulating arousal and wakefulness. The orexin system promotes wakefulness by activating various arousal systems. Medications that block orexin receptors, like Dayvigo, interfere with this wakefulness signaling, thereby promoting sleep [2][3].
What are the clinical studies supporting Dayvigo's efficacy?
Clinical trials have evaluated the efficacy and safety of Dayvigo in adults with insomnia, assessing its impact on sleep onset latency, wakefulness after sleep onset, and total sleep time [3].
Sources:
1. https://www.dayvigo.com/
2. https://www.drugpatentwatch.com/blog/orexin-receptor-antagonists-a-new-class-of-hypnotics/
3. https://www.drugpatentwatch.com/search/dayvigo
4. https://www.drugpatentwatch.com/